NO20025323L - Nye polysykliske indanylimidazoler med alfa2-adrenerg aktivitet - Google Patents

Nye polysykliske indanylimidazoler med alfa2-adrenerg aktivitet

Info

Publication number
NO20025323L
NO20025323L NO20025323A NO20025323A NO20025323L NO 20025323 L NO20025323 L NO 20025323L NO 20025323 A NO20025323 A NO 20025323A NO 20025323 A NO20025323 A NO 20025323A NO 20025323 L NO20025323 L NO 20025323L
Authority
NO
Norway
Prior art keywords
alpha2
indanylimidazoles
adrenergic activity
novel polycyclic
polycyclic
Prior art date
Application number
NO20025323A
Other languages
English (en)
Other versions
NO20025323D0 (no
Inventor
Paavo Huhtala
Arto Karjalainen
Antti Palina
Raimo Virtanen
Jyrki Lehtimaeki
Jari Ratilainen
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Publication of NO20025323L publication Critical patent/NO20025323L/no
Publication of NO20025323D0 publication Critical patent/NO20025323D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20025323A 2000-05-08 2002-11-06 Nye polysykliske indanylimidazoler med alfa2-adrenerg aktivitet NO20025323D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20001065 2000-05-08
PCT/FI2001/000434 WO2001085698A1 (en) 2000-05-08 2001-05-07 New polycyclic indanylimidazoles with alpha2 adrenergic activity

Publications (2)

Publication Number Publication Date
NO20025323L true NO20025323L (no) 2002-11-06
NO20025323D0 NO20025323D0 (no) 2002-11-06

Family

ID=8558343

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20025323A NO20025323D0 (no) 2000-05-08 2002-11-06 Nye polysykliske indanylimidazoler med alfa2-adrenerg aktivitet

Country Status (16)

Country Link
US (1) US6362211B2 (no)
EP (1) EP1280779B1 (no)
JP (1) JP2003532712A (no)
AT (1) ATE302757T1 (no)
AU (2) AU5846901A (no)
CA (1) CA2408290A1 (no)
CZ (1) CZ20023674A3 (no)
DE (1) DE60112917T2 (no)
ES (1) ES2247107T3 (no)
IL (1) IL152401A0 (no)
NO (1) NO20025323D0 (no)
NZ (1) NZ522274A (no)
PE (1) PE20011321A1 (no)
PT (1) PT1280779E (no)
RU (1) RU2002132883A (no)
WO (1) WO2001085698A1 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2835834B1 (fr) * 2002-02-14 2004-04-02 Pf Medicament Nouveaux derives de tricyclo-imidazolines, leur procede de preparation et leur utilisation a titre de medicaments
US8188126B2 (en) 2002-05-16 2012-05-29 Pierre Fabre Medicament Imidazolic compounds and use thereof as alpha-2 adrenergic receptors
FR2839719B1 (fr) * 2002-05-16 2004-08-06 Pf Medicament Nouveaux composes imidazoliques, leur procede de preparation et leur utilisation a titre de medicaments
EP2323734A1 (en) * 2008-08-04 2011-05-25 Schering Corporation Cyclopropylchromene derivatives as modulators of the alpha-2c receptor
US10826751B2 (en) * 2009-12-28 2020-11-03 Telefonaktiebolaget Lm Ericsson (Publ) Management of functional interconnections between application modules on resource nodes in a social web
ES2966641T3 (es) * 2017-06-26 2024-04-23 Bio Rad Europe Gmbh Procedimiento de dilución seriada in situ

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2167408B (en) * 1984-11-23 1988-05-25 Farmos Oy Substituted imidazole derivatives and their preparation and use
FI81092C (fi) * 1986-05-15 1990-09-10 Farmos Oy Foerfarande foer framstaellning av terapeutiskt aktiva 4(5)-(2,3-dihydro-1h-inden-2-yl)-imidazolderivat.
GB2225782A (en) * 1988-12-09 1990-06-13 Farmos Group Limited Imidazole derivatives useful for treatment of diabetes
GB9425211D0 (en) 1994-12-14 1995-02-15 Ucb Sa Substituted 1H-imidazoles
GB9520150D0 (en) 1995-10-03 1995-12-06 Orion Yhtymae Oy New imidazole derivatives

Also Published As

Publication number Publication date
AU2001258469B2 (en) 2005-04-14
JP2003532712A (ja) 2003-11-05
CZ20023674A3 (cs) 2003-09-17
EP1280779B1 (en) 2005-08-24
PE20011321A1 (es) 2002-01-03
PT1280779E (pt) 2005-11-30
NZ522274A (en) 2004-11-26
IL152401A0 (en) 2003-05-29
US20020013356A1 (en) 2002-01-31
CA2408290A1 (en) 2001-11-15
EP1280779A1 (en) 2003-02-05
ATE302757T1 (de) 2005-09-15
WO2001085698A1 (en) 2001-11-15
ES2247107T3 (es) 2006-03-01
US6362211B2 (en) 2002-03-26
AU5846901A (en) 2001-11-20
DE60112917T2 (de) 2006-06-08
NO20025323D0 (no) 2002-11-06
RU2002132883A (ru) 2004-04-20
DE60112917D1 (de) 2005-09-29

Similar Documents

Publication Publication Date Title
HK1075660A1 (en) Polycyclic compounds as potent alpha2-adrenoceptorantagonists
CO5031285A1 (es) Triarilimidazoles
DE60111205D1 (de) Triarylimidazol-derivate als cytokin-inhibitoren
NO20025590D0 (no) Fenylglycin-derivater
DE69613139D1 (de) Heterozyclische fungizide
NO20004090L (no) Kjemiske forbindelser
WO2003059880A1 (fr) Derive d'amino-alcool ou derive d'acide phosphonique et composition medicamenteuse les contenant
HRP20070286T3 (en) Substituted diketopiperazines and their use as oxytocyn antagonists
NZ514662A (en) Amine derivatives
DE60012809D1 (de) 2-Pyridinylguanidine als Urokinase Inhibitoren
ATE175661T1 (de) Benzamid-derivate als vasopressin-antagonisten
RS51193B (sr) Hidantoinski derivati korisni kao inhibitori metaloproteinaza
TR200102540T2 (tr) Heterosiklik bileşimler, ara ürünleri ve elastaz inhibitörleri.
DK1301503T3 (da) Coumarinderivater med COMT-inhiberende aktivitet
NO20025323D0 (no) Nye polysykliske indanylimidazoler med alfa2-adrenerg aktivitet
DE60017374D1 (de) Antibakterielle mittel
UY26568A1 (es) Nuevos derivados de amidas heterocíclicas
ATE473234T1 (de) Trh-ähnliche peptidderivate als inhibitoren des trh-abbauenden ektoenzyms
DE69615657D1 (de) Antifungal fusacandine
BR0110328A (pt) Compostos heterocìclicos com atividade antiinflamatória
ITMI20032102A1 (it) Composti peptidomimetici, procedimento stereoselettivo per la loro preparazione, loro uso come intermedi di sintesi di derivati biologicamente attivi.
ECSP982697A (es) Isoquinolinas

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application